Search





Results 1-5 of 5.
  • previous
  • 1
  • next
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC933312014α-Radioimmunotherapy with 213Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myelomaTEILUF K; SEIDL C.; BLECHERT B.; GAERTNER F. C.; GILBERTZ K.-P.; FERNANDEZ V; BASSERMANN F; ENDELL J; BOXHAMMER R; LECLAIR Stephane; VALLON M.; AICHLER M; FEUCHTINGER A; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC737802013Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationWULBRAND Christian; SEIDL C.; GAERTNER F. C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.; SENEKOWITSCH-SCHMIDTKE R.
JRC680422012Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisESSLER M.; GAERTNER F. C.; NEFF Frauke; BLECHERT B.; SENEKOWITSCH-SCHMIDTKE R.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SEIDL C.
JRC765832012Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrestVALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; WALCH Axel K.; SENEKOWITSCH-SCHMIDTKE R.; ESSLER M.
JRC524352009Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor CellsDRECOLL E.; GAERTNER F. C.; MIEDERER M.; BLECHERT B.; VALLON M.; MÜLLER J.; ALKE A.; SEIDL C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.; ESSLER M.